Restrictive Conditions - Pneumonia

RESTRICTIVE CONDITIONS - PNEUMONIA

GUIDING QUESTIONS

  • Define pneumonia: Pneumonia is defined as an inflammatory process within the lung parenchyma typically initiated by an infection in the lower respiratory tract that extends to the alveoli and lung tissue.

  • Understand the general etiology and pathophysiology of bacterial and viral pneumonia: Bacterial pneumonia often arises from aspiration or inhalation of pathogens, leading to inflammation and consolidation of lung tissue. Viral pneumonia is characterized by a destructive process affecting the respiratory epithelium, often following respiratory tract infections.

  • What part of the lungs does pneumonia affect?: Pneumonia can involve various regions of the lungs, including segmental, lobar, or even affect both lungs, resulting in diffuse pulmonary involvement.

  • What are the 4 categories of pneumonia?:

    1. Community-acquired pneumonia (CAP): Acquired outside of a hospital setting.

    2. Hospital-acquired pneumonia (HAP): Occurs 48 hours or more after admission and was not incubating at the time of admission.

    3. Health-care associated pneumonia (HCAP): Occurs in non-hospitalized patients who have extensive health care contact.

    4. Ventilator-associated pneumonia (VAP): Develops in patients who are mechanically ventilated for more than 48 hours.

  • How does pneumonia lead to restrictive dysfunction?: The inflammatory response can lead to decreased lung compliance and restricted lung expansion due to consolidation and fluid in the alveoli, resulting in impaired gas exchange.

  • How does pneumonia present clinically?: Clinically, pneumonia presents with symptoms such as fever, cough (dry or productive), dyspnea, pleurisy, and physical findings like increased work of breathing and altered lung sounds.

  • Difference between acute and chronic onset?: Acute pneumonia develops rapidly, often within hours to days, while chronic pneumonia has a slower, insidious onset observed over days, weeks, or months.

  • Key differences between bacterial vs. viral pneumonia:

    • Onset and pathophysiology: Bacterial pneumonia usually has a sudden onset and can present with localized findings, while viral pneumonia's onset is more gradual and often bilateral.

    • Stages and/or progression: Bacterial progresses through stages from consolidation to resolution; viral often leads to epithelial damage without the same stages of consolidation.

    • Symptoms: Bacterial pneumonia is typically associated with high fever and productive cough, while viral pneumonia may present with low-grade fever and a nonproductive cough.

    • Examination findings (auscultation, XR, ABG, etc.): Bacterial pneumonia shows unilateral consolidation on chest X-ray, while viral pneumonia presents with bilateral infiltrates.

  • General medical management strategies of pneumonia: Medical management includes identifying the causative organism, administering appropriate antibiotics for bacterial pneumonia, antiviral medications for viral infections, supportive measures such as hydration, and possibly hospitalization for severe cases.

  • Priorities for PT intervention and their differences depending on pneumonia stage: In the acute stage, physical therapy focuses on improving ventilation and gas exchange, while in the resolution stage, activities concentrate on strengthening, endurance training, and airway clearance techniques.

ETIOLOGY

Within the Lung (Intrapulmonary)

  • Interstitial lung disease

  • Pneumonia

  • Pulmonary edema/ARDS

Outside the Lung (Extrapulmonary)

  • Diseases affecting the pleura

  • Disorders of chest wall (e.g., Scoliosis/Kyphosis)

  • Extra thoracic conditions (e.g., Obesity)

  • Impairing ventilatory pump function

  • Impaired respiratory drive (e.g., Traumatic brain injury)

  • Neurologic and Neuromuscular disorders (e.g., Spinal cord injury, ALS)

  • Muscular/Skeletal issues

PNEUMONIA OVERVIEW

  • Definition: Inflammatory process within the lung parenchyma.

  • Process: Typically begins with an infection of the lower respiratory tract that progresses to the alveoli.

  • Categories: CAP, HAP, HCAP, VAP.

  • Significance: Pneumonia is a significant global health issue and the most common infectious cause of death worldwide.

CAUSATIVE AGENTS

  • Types of Agents: Bacteria, viruses, fungi, mycoplasmas.

  • Most Common: Streptococcus pneumoniae (pneumococcus).

  • Onset:

    • Acute: Sudden onset over hours to days.

    • Chronic: Insidious onset over days, weeks, or months.

  • Affect on Lungs: Pneumonia can affect a segment (segmental pneumonia), a whole lobe (lobar pneumonia), one lung side, or the entire lung.

PATHOGENESIS OF BACTERIAL PNEUMONIA

  • Routes of Infection: Commonly through inhalation and aspiration into the lungs.

  • Types of Acute Bacterial Pneumonia:

    • Lobar pneumonia: Inflammation of an entire lobe; characterized by consolidation.

    • Bronchopneumonia: A descending infection originating in bronchi leading to patchy consolidation, typically affecting multiple lobes.

STAGES OF LOBAR PNEUMONIA (BACTERIAL)

  1. Stage 1: Consolidation/Congestion

    • Timeframe: First 24 hours.

    • Features: Lungs appear heavy, red, boggy; characterized by significant cough and breathing distress.

  2. Stage 2: Red Hepatization/Early Consolidation

    • Timeframe: 2-3 days post-consolidation.

    • Appearance: Affected lung regions are red-pink and dry, with a granular texture and marked neutrophil accumulation.

  3. Stage 3: Grey Hepatization/Late Consolidation

    • Timeframe: 2-3 days following early consolidation.

    • Characteristics: The affected lung tissue turns gray due to fibrin deposition and destruction of lung cells.

  4. Stage 4: Resolution

    • Timeframe: After 8-10 days without intervention.

    • Process: The lungs undergo resorption and restoration of normal architecture; macrophages play a critical role in clearing dead cells and debris.

CLINICAL CONSEQUENCES

  • Effects: Results in decreased lung compliance, impaired ventilation, oxygenation issues, increased respiratory efforts, and potential respiratory failure depending on the pneumonia's severity.

CLINICAL PRESENTATION - SYMPTOMS

  • Consolidation and Hepatization Stages Symptoms: High fever & chills, dyspnea, pleurisy, rapid breathing (tachypnea), myalgias.

  • Resolution Stage Symptoms: Characterized by a productive cough with sputum, and overall improvement in clinical condition.

CLINICAL PRESENTATION - OBSERVATION & PHYSICAL EXAM

  • Observations: Look for increased work of breathing, alterations in breath sounds (e.g., bronchial sounds over areas of consolidation).

  • Tests: Arterial blood gas (ABG) analyses may show hypoxemia; an elevated heart rate may be observed in febrile patients.

VIRAL PNEUMONIA

  • Characteristics: Viral pneumonia tends to have a slower, progressive onset and is most often caused by RNA or DNA viruses.

  • Routes of Infection: Primarily through direct inoculation or as a sequel to upper respiratory infections.

  • Pathophysiology: Destroys respiratory epithelium, leading to alveolar damage potentially resulting in ARDS.

PNEUMONIA: VIRAL V. BACTERIAL

Bacterial Pneumonia


Viral Pneumonia

Who?: Often affects immunocompromised individuals or those recovering from respiratory infections.

Who?: Can be mild in healthy individuals but severe in those with underlying health conditions.

Presentation: Sudden onset, unilateral pulmonary findings, accompanied by high fever.

Presentation: Insidious onset, often presents with bilateral infiltrates, and exhibits low-grade fever.

Symptoms: Typically features a productive cough, tends to have leukocytosis.

Symptoms: Often presents with a nonproductive cough and normal white blood cell count.

TESTS

  • Diagnostic Imaging:

    • Chest X-ray: Bacterial pneumonia shows unilateral consolidation; whereas, viral pneumonia may demonstrate bilateral, diffuse infiltrates.

    • Pulmonary Function Testing (PFT): Generally shows reduced lung volumes in affected patients.

DIAGNOSIS

  • Methods: Involves clinical assessment, blood cultures, imaging studies (X-ray/CT scans), and viral serology for specific pathogens.

MEDICAL MANAGEMENT

  • Goals: Focus on treating the underlying cause, identifying the pathogen, and providing appropriate therapeutic interventions.

  • Supportive Care: Includes intravenous hydration, nutritional support, pain control, and cough management as needed.

  • Severity Management: Patients experiencing severe respiratory failure may require hospitalization and potential intubation.

PHYSICAL THERAPY MANAGEMENT (ACUTE CARE)

  • Goals in Consolidation Stage: Enhance gas exchange, optimize ventilation/perfusion (V/Q) ratios, and improve lung expansion. Techniques include patient positioning, mobilization, and breathing exercises.

  • Goals in Resolution Stage: Facilitate improved gas exchange, lung expansion, and airway clearance; employs strategies like deep breathing exercises, functional mobility activities, and strength/endurance training.

REFERENCES

  • Cross, S. Underwood’s Pathology: A Clinical Approach. 7th ed. Elsevier, Inc; 2018.

  • Freeman, A., et al. Viral Pneumonia. StatPearls Publishing; 2022.

  • Gore, Shweta, et al. Essentials of Cardiopulmonary Physical Therapy. 5th ed. Elsevier, Inc; 2021.